chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 hr later-lightheaded, sore arm congestion on the chest. Shortness of breath achy all over, very weak next day - eyes - lower lid - red & puffy head - hurting (temples), sinus (nose) plugged up.
Pain and swelling of joints - hand and feet; symptoms started 2 days after Td injection
Pt reported that her arm was sore after administration and the following day but did not have any type of reaction until the 22nd (2 days after administration- pt reported redness at the injection site and sporadic fever and weakness- she went to an after hours clinic where she reported the dr thought she had bronchitis? (pt has asthma and is a smoker) - I saw the pt on 6/24 and there was indeed redness/swelling at the injection site but she felt well enough to come into work.
This case is a cluster of 5 patients who experienced adverse events following administration of FLUZONE INTRADERMAL; lot number UT4163AA. The event for one patient was captured in case number 2012-01403. Initial report was received from a company representative on 31 January 2012. Five patients had received an Intradermal (ID) injection of FLUZONE; lot number UT4163AA (site, route and date of administration were not provided). On an unspecified date, the patients developed redness, swelling and itching at injection site. No further information was available at the time of this report. The patient's outcome was reported as recovered/resolved. Documents held by sender: No medical follow-up required. Follow up information received on 30 April 2012. Patient's date of birth and gender as female. Nausea and feeling ill were added as new events. Vaccination date was updated to 29 September 2011 and event onset date as 29 September 2011. FLUZONE lot number was updated as UT4163AA. Route of vaccination was updated as intra-dermal and site as Right upper arm.
Information has been received from a consumer concerning her 20 year old female daughter with an allergy to "ZECORE" who on 27-OCT-2007 (also reported as 29-OCT-2007) was vaccinated with the first dose of GARDASIL (route, Lot# and expiration date not reported), on 28-DEC-2007 was vaccinated with the second dose of GARDASIL (route, Lot# and expiration date not reported) and on 29-APR-2008 was vaccinated with the third dose of GARDASIL (route, Lot# and expiration date not reported). The consumer stated that her daughter was experiencing hives on her legs on an unspecified date. The get better and then come back again in 2008. Also the consumer daughter developed welts or a rash at the top of her legs and on her buttock after the second dose of GARDASIL (AE onset date also reported as "back in 2008"). She had been examined by three dermatologist, and general physician. She was diagnosed with Staph and treated with BACTRIM. The patient originally improved but then the rash returned. She was then diagnosed with pityriasis on an unspecified date and treated with dapsone. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
COVID vaccine breakthrough case  3/8/21 dose 1 Moderna 032A21A 4/5/21 dose 2 Moderna 025B21A
heart beat started to beat irregular  and lasted until next morning .When i woke up it was fine.
Itching on arms, neck, and chest. Primarily on left arm, neck and right hand. Itchiness moved around my body over course of few days, including on my legs at one point. Some red spots but no rash. Itchiness felt like when you have a mosquito bite. Was not too bad so didn't take anti-histamine. I still have the itchiness after 5 days but it's getting more and more mild.
Severe nausea, migraines, aches, shakes, fever, muscle soreness, dizziness, diarrhea, mood swings
Left arm redness, pain to injection site. Per MD apply cold compresses. Tylenol as needed
I got an injury; This is a spontaneous report received from a non-contactable consumer or other non hcp.A patient of unspecified age and gender received bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on 2021 as Dose number unknown,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced an injury on 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Starting the next day and still happening, I have bloody boogers everytime I blow my nose, a couple times a day.  I haven't had that happen to me before.
Client was vaccinated in May, 2021 with 2 doses of Moderna vaccine.  Not sure of dates but one was in beginning and one at end of May per client report.  Symptomatic on 8/19 for Covid: cough, fever 103 x 2 days, loss of taste and smell, nausea and vomiting.  Hospitalized 8/24-8/29.  Tested positive for Covid on 8/24.  Reported as breakthrough Covid case in fully vaccinated person.
Previous history covid in March 2021. After first shot reactivating of covid symptoms.  Fatigue,fever,sever back pain,muscle aches,severe lethargy and headache. After second shot, shortness of breath,cough,headache,back pain and muscle weakness reactivated, cough, severe facial rash.
Pt. stated, "I got a headache 3 minutes after getting vaccinated."  Vital signs done:  BP 125/84, HR 90, O2Sat 99%, R 18.  At 3:21pm pt. stated, "I feel better now."  Pt. stated, "I felt a little nauseous."  At 3:27pm pt. reported feeling better and wants to go home.  At. 3:29pm pt. went home with family.
pt recv vax 21MAY97 & 5JUN97 reporter learned that pt was 7 days pregnant;LMP 4MAY97;estimated date of delivery 9FEB98;pregnancy confirmed by test fr hCG;pt devel small amount of soreness in arm @ inj site;neg test for varicella antibodies;
Vaccine given at 10 AM - later that afternoon she started feeling wiped out, couldn't walk, couldn't use hands, weak, couldn't eat, no SOB. Rested all weekend feels better now.
left arm hurts, can barely move her arm; feeling nausea; headache; little tired; actually threw up; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurts, can barely move her arm), NAUSEA (feeling nausea), HEADACHE (headache), FATIGUE (little tired) and VOMITING (actually threw up) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm hurts, can barely move her arm), NAUSEA (feeling nausea), HEADACHE (headache), FATIGUE (little tired), VOMITING (actually threw up) and PYREXIA (low grade fever). At the time of the report, PAIN IN EXTREMITY (left arm hurts, can barely move her arm), NAUSEA (feeling nausea), HEADACHE (headache), FATIGUE (little tired), VOMITING (actually threw up) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug included birth control. Treatment was not reported.
Systemic hives 7 days following vaccination and continued for 2 weeks intermittently. Gastrointestinal pain and diarrhea for 6 weeks. Withdrew socially, stopped responding to name, started "zoning out", stopped progressing with language development for 6 months.
I experienced a terrible headache. I was febrile with chills. I was lethargic and incapable of work. I spent over 2 days in bed with malaise, body aches, and joint pain.  I felt terrible. It took me days to recover.
2 days after vaccination patient developed a red sore injection site and an itchy rash under her arm, by her breast and on neck.  Was advised to contact primary physician and to take Benadryl to help with rash.
Itchy site of injection; itch gotten worse after getting the 2nd and booster doses; scratchy feeling/ got worse when she received the second dose and the booster dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy site of injection; itch gotten worse after getting the 2nd and booster doses) and SCRATCH (scratchy feeling/ got worse when she received the second dose and the booster dose) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy site of injection; itch gotten worse after getting the 2nd and booster doses) and SCRATCH (scratchy feeling/ got worse when she received the second dose and the booster dose). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy site of injection; itch gotten worse after getting the 2nd and booster doses) and SCRATCH (scratchy feeling/ got worse when she received the second dose and the booster dose) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-1 test: positive (Positive) Positive.         Patient stated that she was on concomitant medication.  Patient started feeling an itch in the site of injection and scratchy feeling had not fully subsisted since she got the first dose of the vaccine. Patient stated that it got worse when she received the second dose and the booster dose on 07Jan2022. The patient stated that she never had symptom with any other vaccine before she received the Moderna covid19 vaccine.  Patient had no past history elating to mentioned AE and both Acute and Chronic illnesses at the time of Vaccination.  Treatment medication was not provided by the reported.   This case was linked to MOD-2022-478698, MOD-2022-478868 (Patient Link).
Swelling of the Lips, applied aquaphor was tolerated and continued for 1 month.
Asleep feeling in hands; Swelling in top of hands and wrists; Can't do normal activity; Arm pain,hand pain; Hard to open hands,Ring fingers won't fully exten; Tingling of hand; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MUSCLE SPASTICITY (Hard to open hands,Ring fingers won't fully exten), PARAESTHESIA (Tingling of hand), HYPOAESTHESIA (Asleep feeling in hands), PERIPHERAL SWELLING (Swelling in top of hands and wrists) and IMPAIRED WORK ABILITY (Can't do normal activity) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026I20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Feb-2021, the patient experienced MUSCLE SPASTICITY (Hard to open hands,Ring fingers won't fully exten), PARAESTHESIA (Tingling of hand) and MYALGIA (Arm pain,hand pain). On an unknown date, the patient experienced HYPOAESTHESIA (Asleep feeling in hands), PERIPHERAL SWELLING (Swelling in top of hands and wrists) and IMPAIRED WORK ABILITY (Can't do normal activity). At the time of the report, MUSCLE SPASTICITY (Hard to open hands,Ring fingers won't fully exten), PARAESTHESIA (Tingling of hand), HYPOAESTHESIA (Asleep feeling in hands), PERIPHERAL SWELLING (Swelling in top of hands and wrists), IMPAIRED WORK ABILITY (Can't do normal activity) and MYALGIA (Arm pain,hand pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       treatment given to the patient was: heating pad, physical therapy, cyclobenzaprine, naproxen, meloxicam. no concomitant drugs were used by the patient   This case was linked to MOD-2021-083326 (Patient Link).   Reporter did not allow further contact
7 days after rash on legs bigger and more concentrated in diaper area. Increased temp, motrin helped. Now is itching. Few on trunk and upper extremities. Dx as C.P. by MD ?.
Pt reports that his whole body feels sore, with headache described as an aching in temple areas, going to back of head, neck and back. Rates headache as a # 4-5 on scale of 1-10 and stated this is not the worse headache he has had. He reports nausea, but no emesis and is keeping fluids down. He denies fever, cough and sneezing, and stated he feels like he has the flu. He reported that he was feeling a little under the weather prior to the administration of AVA. He reported that he usually feels bad following immunizations including his flu shot he received in Sep. Stated he has not taken anything for his symptoms. He denied any significant medical history.
I had violent chills and my fever went up to almost 103 degrees.  By noon on 11/16/2013 my temperature was back to normal. I have never had any side effects from a flu shot before, and I have not been sick in a long time. I have heard of others who experienced similar side effects this year.
Dizzy; feels crappy now; Sweaty; Up half of the night; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 28 year-old female patient received bnt162b2 (BNT162B2), administration date 28Sep2021 (Batch/Lot number: unknown) at the age of 28 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Crohn's disease" (unspecified if ongoing), notes: Her niece is remission from Crohn's disease. She had it really bad since a teenager and had all sorts of fusion therapy a long time a ago. She has been in remission for a few years now. There were no concomitant medications. Vaccination history included: Bnt162b2 (received the first dose a few weeks ago and was fine after that), for Covid-19 immunization, reaction(s): "was fine after that". The following information was reported: DIZZINESS (non-serious) with onset 28Sep2021, outcome "recovered" (28Sep2021), described as "Dizzy"; FEELING ABNORMAL (non-serious) with onset Sep2021, outcome "not recovered", described as "feels crappy now"; HYPERHIDROSIS (non-serious) with onset Sep2021, outcome "not recovered", described as "Sweaty"; SLEEP DISORDER (non-serious) with onset Sep2021, outcome "unknown", described as "Up half of the night". Additional information: The reporter is the Patient's aunt. Batch/lot, NDC number and Expiry Date were Unknown, Reason for no lot number is her niece would have that information on her card. The Vaccination Facility Type was Pharmacy/drug store. Her niece is remission from Crohn's disease. She had it really bad since a teenager and had all sorts of fusion therapy a long time ago. She has been in remission for a few years now. The reporter is a consumer reported that she got a text from her niece who got her second shot of the Pfizer Covid-19 Vaccine, and she was so dizzy that she could not drive home. The patient's mother reported it to the pharmacy. The patient is in bed at home. She does not know if her niece should go to the hospital. Her niece had to leave her car at the pharmacy and her mother had to go pick her up. The reporter said that her niece received the Pfizer Covid-19 Vaccine. The reporter said that her niece was fine after a half hour with the dizziness. Her niece was up half the night and feels crappy now and is taking a nap. Her niece was sweaty but had no fever. Her niece received the first dose a few weeks ago and was fine after that. Caller said that she wanted to get this reported because she is afraid of Guillain Barre because she knows you can get that from vaccines. After listening to the recording, reporter states that she thinks the patient received the vaccine the day before on 28Sep2021, and the dizziness occurred immediately after receiving the vaccine.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt had stroke-like symptoms such as muscle weakness on one side, slurred speech, confusion, sent to Emergency Room - Brain scan - no stroke, sent to hospital - they said possible Adem. and administered steroids.  7/13/09 Hospital records received DOS 12/28/01 to 12/31/01. Assessment: Polyneuropathy. Patient presented with acute onset of right-sided weakness with right-sided facial droop. Decreasd sensation right upper and lower extremitus. Difficulty emptying bladder. Bilateral pes cavus. Calculations mildly impaired. Decrease in muscle bulk lower extremities. Postural tremor left upper extremity. Plantar response flexor on the left, extensor on the right. Too weak to stand or walk. IV steroids administered with dramatic recovery. Discharged in good condition.   8/3/09 ICD-9 Codes: 780.9 Other General Symptoms  357.8  Inflammatory and toxic neuropathy
complications sleeping; nightmares; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SLEEP DISORDER (complications sleeping) and NIGHTMARE (nightmares) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (complications sleeping) and NIGHTMARE (nightmares). At the time of the report, SLEEP DISORDER (complications sleeping) and NIGHTMARE (nightmares) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's medical history and relevant concomitant medications weren't reported. Treatment information was not provided.
Received Meningococcal Vaccine in Left Deltoid. Experienced itching and redness with 5mm x 5mm induration. It improved by 09/29/2011 with less redness and swelling.
Red, hot, itchy rash. Started at vaccination site. Has spread across and down arm.   Is now  across full front of arm and down to 2 inches above elbow. Have treated with oral  and topical antihistamines, along with Hydrocortisone cream and ice.
3 hours after injection, he developed pain of the L arm and L shoulder that then became difficult to move due to pain and some warmth to the arm.
The patient got real dizzy and started to shaking (possible seizure).  The patient was assisted to the ground and moved to a fetal position on his right side. 911 was called by the pharmacy technician. The patient slowly started  to recover and he stated he started feeling better as paramedics arrived. The paramedics took the patient away to a nearby hospital.
2nd day post vax bright red circle 5cm;3rd day small pox type circle, burns, swollen, can't sleep-MD treating sx;
Reconstituted with sterile water instead of the provided diluent portion; Administration of the Shingrix vaccine reconstituted with sterile water; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 57-year-old male patient who received Herpes zoster (Shingrix) (batch number K735H, expiry date 13th September 2022) for prophylaxis.   On 4th June 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 4th June 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that the patient was administered with the Shingrix 2nd dose reconstituted with sterile water instead of the provided diluent portion, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. No further events were reported.  The HCP consented to follow up.
Fever / Fever of 38 degrees; fever; Chills; Fatigued; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 38 (Inconclusive) Fever of 38 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.
Patient received first dose of Covid Pfizer vaccine.  Shortly after getting the vaccine, patient was sitting in our  waiting room and yelled out for help.  She reported feeling faint and nauseous.  We got the patient a bottle of water.  Patient wanted to move back to the immunization room to lay down, so we assisted her in getting there. Pharmacist sat there with her while she recovered, she reported feeling better after laying down.  Patient decided after about 15 minutes that she was feeling better and ready to leave.
Pt. states after receiving the 2nd Moderna vaccine 06/16/2021, started experiencing severe arm pain and slight fever *lasting 24hrs. Arm pain continuing, no noted Primary visit. Ibuprofen use for pain.
Information has been received from registered nurse (R.N.) concerning a 13-month-old male who on 30-MAY-2007 was vaccinated with a dose of PROQUAD (lot# 656551/1532F). On 05-JUN-2007 the patient broke out in a rash. On 07-Jun-2007 the patient was diagnosed with chickenpox breakthrough. The R.N. reported that the patient developed a full blown case of chickenpox. The patient was covered with about 75 lesions from his knees up. The R.N. reported that she did not think that the patient was exposed to anyone with chickenpox but she did not see the patient. Unspecified medical attention was sought. The outcome is reported as not recovered. No product quality complaint was involved. Additional information has been requested.
Cl came down w/shingles 6/13 after receiving Zostavax 12/07.